Madrid, Spain – 30 August 2025: More patients with hypercholesterolaemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced detailed results from CORALreef AddOn, an active comparator study designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results